Stockscreener 앱 받기
5.01
3.73%
0.18
시장 영업 전:
4.99
-0.02
-0.40%
Nyxoah Sa 주식(NYXH)의 최신 뉴스
Nyxoah receives Medicare reimbursement increases for Genio - MSN
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
PRN_FinancialWrapper | PR NewswireNyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - FinancialContent
Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH) - Defense World
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $5.87 - 富途牛牛
Nyxoah announces commercial launch of Genio system in the Netherlands - MSN
Nyxoah launches Genio therapy in Netherlands and closes first €22.5 million tranche of convertible notes - MSN
Nyxoah price target lowered to EUR 5 from EUR 7 at Baird - MSN
Nyxoah Announces Issuance of First Tranche of Convertible Bonds - The Manila Times
Is Nyxoah SA stock positioned for digital transformationQuarterly Trade Review & Consistent Return Investment Signals - Улправда
Nyxoah Launches Genio Therapy in Netherlands and Closes First €22.5 Million Tranche of Convertible Notes - TipRanks
Earnings Recap: Is Nyxoah SA stock a good choice for value investorsJuly 2025 Highlights & Target Return Focused Picks - moha.gov.vn
Can Nyxoah SA stock deliver strong Q4 earningsQuarterly Growth Report & Smart Swing Trading Alerts - DonanımHaber
Is Nyxoah SA stock a good choice for value investorsBull Run & Free Technical Confirmation Trade Alerts - Bölüm Sonu Canavarı
Is Nyxoah SA (5YI) stock undervalued historicallyJuly 2025 Sentiment & Daily Profit Maximizing Tips - DonanımHaber
How Nyxoah SA stock performs in high volatility markets2025 Historical Comparison & Expert Curated Trade Setups - ulpravda.ru
Nyxoah Launches New OSA Therapy | Patient-Centric Breakthrough - Precedence Research
Why Nyxoah SA stock is recommended by analystsTake Profit & Step-by-Step Swing Trade Plans - Улправда
Nyxoah Launches Genio Neurostimulator System in the Netherlands - marketscreener.com
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands - FinancialContent
Nyxoah (NASDAQ:NYXH) Trading Down 2.9%Here's What Happened - MarketBeat
Nyxoah (NASDAQ:NYXH) Trading Down 2.9% – Here’s What Happened - Defense World
Nyxoah announces shareholding changes as Robert Taub surpasses 10% threshold - MSN
Critical Analysis: Nyxoah (NASDAQ:NYXH) & P3 Health Partners (NASDAQ:PIII) - Defense World
Nyxoah Announces Shareholding Changes as Robert Taub Surpasses 10% Threshold - TipRanks
How Nyxoah SA (5YI) stock compares with tech leadersWeekly Stock Analysis & Community Verified Trade Signals - Newser
Will Nyxoah SA stock outperform international peersIPO Watch & Accurate Technical Buy Alerts - Newser
Is Nyxoah SA stock a buy for dividend growthJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Will Nyxoah SA (5YI) stock remain on Wall Street radar2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Publication relating to transparency notifications - marketscreener.com
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - MSN
Can Nyxoah SA (5YI) stock sustain institutional flowsJuly 2025 Intraday Action & Daily Chart Pattern Signals - Newser
What MACD trends signal for Nyxoah SA (5YI) stock2025 Dividend Review & Verified Entry Point Signals - Newser
Nyxoah’s Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - Sleep Review
Why The Narrative Around Nyxoah Is Shifting Amid Fresh Developments and Analyst Caution - Yahoo Finance
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Nyxoah (NASDAQ: NYXH) schedules webcast fireside chat at Piper Sandler healthcare conference - Stock Titan
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q3 2025 Earnings Call Transcript - MSN
Nyxoah’s Genio therapy gets significant 2026 Medicare reimbursement increases under final CMS rule - MSN
01 Communique (TSXV: ONE) teams with Turnium to expand IronCAP X quantum-safe email - Stock Titan
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - Yahoo Finance
Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ... By GuruFocus - Investing.com Canada
Will Supply Chain Issues Impact Indian Toners Developers Limiteds PerformanceExit Strategy Tips & High Profit Investment Ideas - earlytimes.in
Will Nyxoah SA (5YI) stock extend growth storyCPI Data & Accurate Technical Buy Alerts - newser.com
Can Nyxoah SA stock sustain free cash flow growth2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Why Nyxoah SA (5YI) stock attracts wealthy investorsIndex Update & Consistent Growth Equity Picks - newser.com
Nyxoah (NASDAQ: NYXH) Reports 43,026,460 Voting Rights and Share Capital Update - Stock Titan
Why Nyxoah SA stock is seen as undervaluedJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Can Nyxoah SA stock sustain market leadershipJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
0.51%
1.30%
자본화:
|
볼륨(24시간):